{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:30:21Z","timestamp":1789903821986,"version":"4.0.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","valueinhealthjournal.com","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.jval.2016.05.005","type":"journal-article","created":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T22:32:28Z","timestamp":1467412348000},"page":"819-827","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Value for Money in H1N1 Influenza: A Systematic Review of the Cost-Effectiveness of Pandemic Interventions"],"prefix":"10.1016","volume":"20","author":[{"given":"H\u00e9l\u00e8ne","family":"Pasquini-Descomps","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Brender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Maradan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jval.2016.05.005_bib1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.puhe.2010.12.007","article-title":"Challenges of global surveillance during an influenza pandemic","volume":"125","author":"Briand","year":"2011","journal-title":"Public Health"},{"key":"10.1016\/j.jval.2016.05.005_bib2","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/irv.12090","article-title":"Unresolved issues in risk communication research: the case of the H1N1 pandemic (2009\u20132011)","volume":"7","author":"Barrelet","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.jval.2016.05.005_bib3","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/irv.12074","article-title":"Estimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries","volume":"7","author":"Van Kerkhove","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.jval.2016.05.005_bib4","unstructured":"World Health Organization. Public health measures during the influenza A (H1N1) 2009 pandemic: WHO Technical Consultation, Gammarth, Tunisia, 26-28 October 2010: Meeting Report 2011. Available from: http:\/\/apps.who.int\/iris\/handle\/10665\/70747. [Accessed March 10, 2014]."},{"key":"10.1016\/j.jval.2016.05.005_bib5","doi-asserted-by":"crossref","first-page":"e30333","DOI":"10.1371\/journal.pone.0030333","article-title":"Systematic review of economic evaluations of preparedness strategies and interventions against influenza pandemics","volume":"7","author":"Perez Velasco","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jval.2016.05.005_bib6","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/cid\/civ088","article-title":"Standardizing scenarios to assess the need to respond to an influenza pandemic","volume":"60","author":"Meltzer","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jval.2016.05.005_bib7","series-title":"World.","article-title":"Health Policy in a Globalising","author":"Kumaranayake","year":"2001"},{"key":"10.1016\/j.jval.2016.05.005_bib8","series-title":"Principles and Standards for Benefit\u2013Cost Analysis.","first-page":"110","article-title":"Principles and standards for benefit\u2013cost analysis of public health preparedness and pandemic mitigation programs","author":"Cook","year":"2013"},{"key":"10.1016\/j.jval.2016.05.005_bib9","first-page":"1459","article-title":"Japan\u2019s action to combat pandemic influenza (A\/H1N1)","author":"Shobayashi","year":"2010","journal-title":"J Jpn Med Assoc"},{"issue":"Suppl 2","key":"10.1016\/j.jval.2016.05.005_bib10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/irv.12091","article-title":"Assessing key model parameters for economic evaluation of pandemic influenza interventions: the data source matters","volume":"7","author":"Praditsitthikorn","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.jval.2016.05.005_bib11","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1586\/erp.09.56","article-title":"Mitigation of pandemic influenza: review of cost-effectiveness studies","volume":"9","author":"Lugn\u00e9r","year":"2009","journal-title":"Exp Rev Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.jval.2016.05.005_bib12","first-page":"26","article-title":"Cost effectiveness analyses of influenza A (H1N1) vaccination programs: how accurate were they?","volume":"6","author":"Beeler","year":"2014","journal-title":"JIDI"},{"key":"10.1016\/j.jval.2016.05.005_bib13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.mbs.2011.10.007","article-title":"Attack rates of seasonal epidemics","volume":"235","author":"Katriel","year":"2012","journal-title":"Math Biosci"},{"key":"10.1016\/j.jval.2016.05.005_bib14","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1186\/1471-2334-14-480","article-title":"Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: a systematic review of the literature.","volume":"14","author":"Biggerstaff","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jval.2016.05.005_bib15","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMra1000449","article-title":"Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection","volume":"362","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jval.2016.05.005_bib16","first-page":"34","article-title":"Is a mass prevention and control program for pandemic (H1N1) 2009 good value for money? Evidence from the Chinese Experience","volume":"41","author":"Wang","year":"2012","journal-title":"Iran J Public Health"},{"key":"10.1016\/j.jval.2016.05.005_bib17","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3201\/eid1807.120191","article-title":"Costing framework for international health regulations (2005)","volume":"18","author":"Katz","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jval.2016.05.005_bib18","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2014.19.3.20680","article-title":"A new laboratory-based surveillance system (Respiratory DataMart System) for influenza and other respiratory viruses in England: results and experience from 2009 to 2012","volume":"19","author":"Zhao","year":"2014","journal-title":"Euro Surveill"},{"key":"10.1016\/j.jval.2016.05.005_bib19","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.2105\/AJPH.2013.301353","article-title":"We can have it all: improved surveillance outcomes and decreased personnel costs associated with electronic reportable disease surveillance, North Carolina, 2010","volume":"103","author":"Samoff","year":"2013","journal-title":"Am J Public Health"},{"key":"10.1016\/j.jval.2016.05.005_bib20","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1098\/rsif.2010.0715","article-title":"Strategies for antiviral stockpiling for future influenza pandemics: a global epidemic-economic perspective","volume":"8","author":"Carrasco","year":"2011","journal-title":"J Royal Soc Interface"},{"key":"10.1016\/j.jval.2016.05.005_bib21","article-title":"Neuraminidase inhibitors for preventing and treating influenza in adults and children","volume":"4","author":"Jefferson","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jval.2016.05.005_bib22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1086\/649867","article-title":"Health outcomes and costs of community mitigation strategies for an influenza pandemic in the United States","volume":"50","author":"Perlroth","year":"2010","journal-title":"Clinical Infect Dis"},{"key":"10.1016\/j.jval.2016.05.005_bib23","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.3201\/eid1512.090902","article-title":"Cost-effectiveness analysis of hospital infection control response to an epidemic respiratory virus threat","volume":"15","author":"Dan","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jval.2016.05.005_bib24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2149\/tmh.2011-09","article-title":"Behavior of adult influenza patients during the 2009 pandemic after outpatient clinic presentations at a hospital in Tokyo, Japan","volume":"39","author":"Nonaka","year":"2011","journal-title":"Trop Med Health"},{"key":"10.1016\/j.jval.2016.05.005_bib25","first-page":"e1","article-title":"Economic model for emergency use authorization of intravenous peramivir","volume":"17","author":"Lee","year":"2011","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.jval.2016.05.005_bib26","doi-asserted-by":"crossref","first-page":"e11284","DOI":"10.1371\/journal.pone.0011284","article-title":"To test or to treat? An analysis of influenza testing and antiviral treatment strategies using economic computer modeling","volume":"5","author":"Lee","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jval.2016.05.005_bib27","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1111\/j.1524-4733.2009.00629.x","article-title":"Cost-effectiveness analysis of oseltamivir for influenza treatment considering the virus emerging resistant to the drug in Japan","volume":"12","author":"Nagase","year":"2009","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2016.05.005_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2011.07.001","article-title":"Cost-effectiveness of oseltamivir treatment for children with uncomplicated seasonal influenza","volume":"160","author":"Lavelle","year":"2012","journal-title":"J Pediatr"},{"key":"10.1016\/j.jval.2016.05.005_bib29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S2213-2600(14)70041-4","article-title":"Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data","volume":"2","author":"Muthuri","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jval.2016.05.005_bib30","first-page":"2199","article-title":"Cost-effectiveness analysis of vaccination and self-isolation in case of H1N1","author":"Yarmand","year":"2010","journal-title":"IEEE"},{"key":"10.1016\/j.jval.2016.05.005_bib31","doi-asserted-by":"crossref","first-page":"e22308","DOI":"10.1371\/journal.pone.0022308","article-title":"Cost-effectiveness of 2009 pandemic influenza A(H1N1) vaccination in the United States","volume":"6","author":"Prosser","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jval.2016.05.005_bib32","doi-asserted-by":"crossref","first-page":"19333","DOI":"10.2807\/ese.14.37.19333-en","article-title":"Economic consequences to society of pandemic H1N1 influenza 2009\u2014preliminary results for Sweden","volume":"14","author":"Brouwers","year":"2009","journal-title":"Euro Surveill"},{"key":"10.1016\/j.jval.2016.05.005_bib33","first-page":"40","article-title":"A cost effectiveness analysis of the H1N1 vaccine strategy for Ontario, Canada","volume":"3","author":"Durbin","year":"2011","journal-title":"J Infect Dis Immun"},{"key":"10.1016\/j.jval.2016.05.005_bib34","doi-asserted-by":"crossref","first-page":"829","DOI":"10.7326\/0000605-200912150-00157","article-title":"Effectiveness and cost-effectiveness of vaccination against pandemic (H1N1) 2009","volume":"151","author":"Khazeni","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jval.2016.05.005_bib35","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1086\/649013","article-title":"Economic value of seasonal and pandemic influenza vaccination during pregnancy","volume":"49","author":"Beigi","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jval.2016.05.005_bib36","doi-asserted-by":"crossref","first-page":"6210","DOI":"10.1016\/j.vaccine.2010.07.010","article-title":"Is a mass immunization program for pandemic (H1N1) 2009 good value for money? Evidence from the Canadian experience","volume":"28","author":"Sander","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jval.2016.05.005_bib37","first-page":"1","article-title":"Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"50","author":"Bridges","year":"2001","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jval.2016.05.005_bib38","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2334-10-14","article-title":"Public health and economic impact of vaccination with 7-valent pneumococcal vaccine (PCV7) in the context of the annual influenza epidemic and a severe influenza pandemic","volume":"10","author":"Rubin","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jval.2016.05.005_bib39","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1126\/science.1175570","article-title":"Optimizing influenza vaccine distribution","volume":"325","author":"Medlock","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.jval.2016.05.005_bib40","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/1471-2458-11-353","article-title":"Would school closure for the 2009 H1N1 influenza epidemic have been worth the cost? A computational simulation of Pennsylvania","volume":"11","author":"Brown","year":"2011","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jval.2016.05.005_bib41","doi-asserted-by":"crossref","first-page":"e22087","DOI":"10.1371\/journal.pone.0022087","article-title":"Cost-effective strategies for mitigating a future influenza pandemic with H1N1 2009 characteristics","volume":"6","author":"Halder","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jval.2016.05.005_bib42","doi-asserted-by":"crossref","first-page":"e97297","DOI":"10.1371\/journal.pone.0097297","article-title":"The effects of school closures on influenza outbreaks and pandemics: systematic review of simulation studies","volume":"9","author":"Jackson","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jval.2016.05.005_bib43","doi-asserted-by":"crossref","first-page":"e50228","DOI":"10.1371\/journal.pone.0050228","article-title":"Attack rates assessment of the 2009 pandemic H1N1 influenza A in children and their contacts: a systematic review and meta-analysis","volume":"7","author":"Glatman-Freedman","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jval.2016.05.005_bib44","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1086\/652647","article-title":"Clinical attack rate and presentation of pandemic H1N1 influenza versus seasonal influenza A and B in a pediatric cohort in Nicaragua","volume":"50","author":"Gordon","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jval.2016.05.005_bib45","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3934\/mbe.2011.8.141","article-title":"Modeling control strategies for concurrent epidemics of seasonal and pandemic H1N1 influenza","volume":"8","author":"Prosper","year":"2011","journal-title":"Math Biosci Eng"},{"key":"10.1016\/j.jval.2016.05.005_bib46","doi-asserted-by":"crossref","first-page":"e1003635","DOI":"10.1371\/journal.pcbi.1003635","article-title":"Spatial transmission of 2009 pandemic influenza in the US","volume":"10","author":"Gog","year":"2014","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.jval.2016.05.005_bib47","doi-asserted-by":"crossref","first-page":"e1002225","DOI":"10.1371\/journal.ppat.1002225","article-title":"Transmission characteristics of the 2009 H1N1 influenza pandemic: comparison of 8 southern hemisphere countries","volume":"7","author":"Opatowski","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jval.2016.05.005_bib48","article-title":"Use IT to minimize impact of flu crisis","author":"Ashford","year":"2009","journal-title":"Comput Wkly"},{"key":"10.1016\/j.jval.2016.05.005_bib49","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jtbi.2012.01.032","article-title":"Economic analysis of the use of facemasks during pandemic (H1N1) 2009","volume":"300","author":"Tracht","year":"2012","journal-title":"J Theor Biol"},{"key":"10.1016\/j.jval.2016.05.005_bib50","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1471-2458-10-138","article-title":"Self-reported anticipated compliance with physician advice to stay home during pandemic (H1N1) 2009: results from the 2009 Queensland Social Survey","volume":"10","author":"Brown","year":"2010","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jval.2016.05.005_bib51","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4103\/2277-9531.127556","article-title":"Determination of preventive behaviors for pandemic influenza A\/H1N1 based on protection motivation theory among female high school students in Isfahan","volume":"3","author":"Sharifirad","year":"2014","journal-title":"Iran J Educ Health Promot"},{"key":"10.1016\/j.jval.2016.05.005_bib52","series-title":"Making Choices in Health: WHO Guide to Cost-Effectiveness Analysis","author":"Edejer","year":"2003"},{"key":"10.1016\/j.jval.2016.05.005_bib53","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1046\/j.1365-2672.2001.01492.x","article-title":"A history of influenza","volume":"91","author":"Potter","year":"2001","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.jval.2016.05.005_bib54","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1080\/01621459.1922.10502488","article-title":"Long-time cycles of pandemic influenza","volume":"18","author":"Eichel","year":"1922","journal-title":"J Am Stat Assoc"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301516304922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301516304922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T16:25:46Z","timestamp":1536596746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301516304922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S1098301516304922"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2016.05.005","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Value for Money in H1N1 Influenza: A Systematic Review of the Cost-Effectiveness of Pandemic Interventions","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2016.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}